Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
NCT00406991Phase 2Completed
- Sponsor
- Schepens Eye Research Institute
- Start
- Jun 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of aspirin and clopidogrel in diabetic retinopathy (DR) (4 arms), sponsored by Schepens Eye Research Institute. Primary endpoint: Retinal blood flow at 2 months. Started Jun 2003; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT00406991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406991.